Intensive Outpatient Versus Outpatient Treatment With Buprenorphine Among African Americans

Drug Dependence Clinical Trial

Official title: Intensive Outpatient v. Outpatient Treatment With Buprenorphine Among African Americans

Status Completed

Clinical Trial Summary

The purpose of this study is to compare the effectiveness of different levels of counseling (intensive outpatient versus standard outpatient) on treatment outcomes for African American adult patients receiving buprenorphine in 2 formerly "drug-free" programs.

Clinical Trial Description

This two-group randomized clinical trial will test the effectiveness of intensive outpatient (IOP) v. standard outpatient (OP) treatment in 272 heroin-dependent African American adults receiving buprenorphine in 2 formerly "drug-free" programs. Participants will be randomly assigned to one of the two treatment intensity conditions at intake and assessed at baseline, 3-, and 6-months post-baseline to determine treatment retention, frequency and severity of heroin and cocaine use, self-reported HIV-risk, quality of life, and to determine DSM-IV criteria for Full or Partial Remission of Opioid Dependence. Furthermore, patient factors potentially critical for treatment success (e.g., attitudes towards buprenorphine and average buprenorphine dose while in treatment) will be examined to determine their importance in influencing treatment outcomes. Moreover, both patient and staff attitudes and average buprenorphine dose will be evaluated to determine their respective relationships to treatment experiences and treatment retention. ;

Related Conditions & MeSH terms

• Drug Dependence
• Substance-Related Disorders

• NCT number: NCT01096550
• Study type: Interventional
• Source: Friends Research Institute, Inc.
• Status: Completed
• Phase: N/A
• Start date: March 2010
• Completion date: October 2011